Celebrating 50 years of neuroscience research at Lilly's Erl Wood site

IF 0.6 Q4 CLINICAL NEUROLOGY

Future Neurology Pub Date : 2017-12-01 DOI:10.2217/FNL-2017-0023

Adam Price-Evans

引用次数: 0

查看原文本刊更多论文

庆祝礼来公司厄尔伍德基地神经科学研究50周年

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Future Neurology CLINICAL NEUROLOGY-

CiteScore

2.10

自引率

0.00%

发文量

期刊介绍： The neurological landscape is changing rapidly. From the technological perspective, advanced molecular approaches and imaging modalities have greatly increased our understanding of neurological disease, with enhanced prospects for effective treatments in common but very serious disorders such as stroke, epilepsy, multiple sclerosis and Parkinson’s disease. Nevertheless, at the same time, the healthcare community is increasingly challenged by the rise in neurodegenerative diseases consequent upon demographic changes in developed countries.